Acute Intermittent Porphyria Market Growing Stupendously at 5.6% of CAGR with Dahaner, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc. and other

Acute Intermittent Porphyria Market - Key Players

Some of key the players in the market are:

Dahaner (U.S.)
Hoffmann-La Roche Ltd (Switzerland)
Bio-Rad Laboratories, Inc. (U.S.)
Siemens AG (U.S.)
ARKRAY, Inc. (Japan)
Sysmex Corporation (Japan)
ACON Laboratories, Inc. (U.S.)

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4713 .

Acute Intermittent Porphyria Market - Segmentation

The global acute intermittent porphyria market is segmented on the basis by diagnosis, by treatment, and by end user. On the basis of diagnosis, it is segmented into blood test, urine test, serum test, DNA test, and others. On the basis of treatment, it is segmented into gonadotropin-releasing hormone analogues, prophylactic hematin infusions, and others. On the basis of end user, it is segmented into hospitals & clinics, research centers, and others.

Acute Intermittent Porphyria Market – Intended Audience

Pharmaceutical Companies
Research and Development (R&D) Companies
Government Research Institute
Academic Institutes and Universities
Medical Research Laboratories
Market Research and Consulting Service Providers
Potential Investors

Acute Intermittent Porphyria Market – Overview

Acute intermittent porphyria (AIP) is a genetic metabolic disorder. It affects the production of heme, the oxygen-binding prosthetic group of hemoglobin. Generally, it is characterized by a deficiency of the enzyme porphobilinogen deaminase. The Global Acute Intermittent Porphyria Market is expected to grow at a CAGR of 5.6 % during the forecast period 2018-2023.

The major causes of acute intermittent porphyria are abnormal urinary color, anorexia, insomnia, myalgia, and urinary retention. In some cases, AIP develops liver cancer (hepatocellular carcinoma), and some develop kidney failure. Other symptoms include gastrointestinal issues, urinary tract issues, neurological issues, psychiatric issues.

The acute intermittent porphyria market growth is majorly attributed to the increasing prevalence of the metabolic disorders, gastrointestinal issues, urinary tract issues, and healthcare insurance coverage. Moreover, increasing geriatric population will drive the market growth.

According to the Economic and Social Commission for Asia and the Pacific (ESCAP), in 2016, approximately 12.4% of the population in the region was over 60 years. According to Asian Development Bank, it was estimated that by 2050, 15% of total Malaysian population will be over 65 year old and in China, the elderly population will reach over 300 million by 2050. Thus, the increasing geriatric population in Asia is likely to help the growth of the market over the forecast period.

According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.

Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/4713 .

According to the American Liver Foundation, there is an increasing the prevalence of liver disease in the U.S. from then last few years. It further stated that at least 30 million people have some form of liver disease.

However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.

Acute Intermittent Porphyria Market - Regional Analysis

The Americas dominate the global acute intermittent porphyria market owing to the presence of huge patient population with gastrointestinal problems, neurological issues, high healthcare spending, and increasing government support for research & development.

Europe holds the second largest share of the global acute intermittent porphyria market as result of increasing focus of various government agencies on the treatment of rare diseases such as acquired aplastic anemia. Moreover, the growing public awareness about acquired aplastic anemia likely to boost the Europe market.

Asia Pacific is the fastest growing acute intermittent porphyria market across the globe. Japan holds the major share of the regional market due to availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in China and India over the forecasted period.

The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

List of Tables

Table 1 Acute Intermittent Porphyria Industry Synopsis, 2017-2023

Table 2 Global Acute Intermittent Porphyria Market Estimates and Forecast, 2017-2023, (USD Million)

Table 3 Global Acute Intermittent Porphyria Market by Region, 2017-2023, (USD Million)

List of Figures

Figure 1 Research Process

Figure 2 Segmentation for Global Acute Intermittent Porphyria Market

Figure 3 Segmentation Market Dynamics for Acute Intermittent Porphyria Market

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/4713 .

Continued….

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.